187 related articles for article (PubMed ID: 35534796)
1. RUNX1 is a promising prognostic biomarker and related to immune infiltrates of cancer-associated fibroblasts in human cancers.
Tuo Z; Zhang Y; Wang X; Dai S; Liu K; Xia D; Wang J; Bi L
BMC Cancer; 2022 May; 22(1):523. PubMed ID: 35534796
[TBL] [Abstract][Full Text] [Related]
2. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
3. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
4. Multi-omics analysis of the oncogenic role of optic
Wu Z; Xu N; Li G; Yang W; Zhang C; Zhong H; Wu G; Chen F; Li D
Aging (Albany NY); 2023 Nov; 15(22):12982-12997. PubMed ID: 37980164
[TBL] [Abstract][Full Text] [Related]
5. Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer.
Xu Y; Shen M; Peng Y; Liu L; Tang L; Yang T; Pu D; Tan W; Zhang W; Liu S
Biomed Res Int; 2022; 2022():4632453. PubMed ID: 36082153
[TBL] [Abstract][Full Text] [Related]
6. Dysregulated RUNX1 Predicts Poor Prognosis by Mediating Epithelialmesenchymal Transition in Cervical Cancer.
Zheng LL; Cai L; Zhang XQ; Lei Z; Yi CS; Liu XD; Yang JG
Curr Med Sci; 2022 Dec; 42(6):1285-1296. PubMed ID: 36544038
[TBL] [Abstract][Full Text] [Related]
7. Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer.
Chen P; Xu J; Cui Z; Wu S; Xie T; Zhang X
Front Immunol; 2023; 14():1071675. PubMed ID: 36761737
[TBL] [Abstract][Full Text] [Related]
8. Expression patterns and prognostic value of RUNX genes in kidney cancer.
Gao K; Zhang F; Chen K; Li W; Guan YB; Xu ML; Chong T; Dai ZM
Sci Rep; 2021 Jul; 11(1):14934. PubMed ID: 34294773
[TBL] [Abstract][Full Text] [Related]
9. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value and immune characteristics of RUNX gene family in human cancers: a pan-cancer analysis.
Zhao H; Chen Y; Shen P; Gong L
Aging (Albany NY); 2022 May; 14(9):4014-4035. PubMed ID: 35522574
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and immunological role of Fam20C in pan-cancer.
Liu X; Zhan Y; Xu W; Liu X; Geng Y; Liu L; Da J; Wang J; Zhang X; Jin H; Liu Z; Guo S; Zhang B; Li Y
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33306121
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer Analysis.
Liu P; Wang X; Pan L; Han B; He Z
Front Immunol; 2022; 13():901784. PubMed ID: 35720327
[TBL] [Abstract][Full Text] [Related]
13. Identification of RUNX1 and IFNGR2 as prognostic-related biomarkers correlated with immune infiltration and subtype differentiation of low-grade glioma.
Zhang X; Chu H; Cheng Y; Ren J; Wang W; Liu X; Yan X
Biomol Biomed; 2023 May; 23(3):405-425. PubMed ID: 36321611
[TBL] [Abstract][Full Text] [Related]
14. A Pan-Cancer Analysis Reveals CLEC5A as a Biomarker for Cancer Immunity and Prognosis.
Chen R; Wu W; Chen SY; Liu ZZ; Wen ZP; Yu J; Zhang LB; Liu Z; Zhang J; Luo P; Zeng WJ; Cheng Q
Front Immunol; 2022; 13():831542. PubMed ID: 35979347
[TBL] [Abstract][Full Text] [Related]
15. Global DNA Methylation Analysis of Cancer-Associated Fibroblasts Reveals Extensive Epigenetic Rewiring Linked with RUNX1 Upregulation in Breast Cancer Stroma.
Halperin C; Hey J; Weichenhan D; Stein Y; Mayer S; Lutsik P; Plass C; Scherz-Shouval R
Cancer Res; 2022 Nov; 82(22):4139-4152. PubMed ID: 36287637
[TBL] [Abstract][Full Text] [Related]
16. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
[TBL] [Abstract][Full Text] [Related]
17. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
Front Immunol; 2021; 12():646523. PubMed ID: 33679809
[TBL] [Abstract][Full Text] [Related]
18. Research on the oncogenic role of the house-keeping gene
Shen C; Li W; Wang Y
Transl Cancer Res; 2023 Mar; 12(3):525-535. PubMed ID: 37033358
[TBL] [Abstract][Full Text] [Related]
19. Multiomics data identifies RSPO2 as a prognostic biomarker in human tumors associated with pan-cancer.
Srivastava A; Srivastava S
Adv Protein Chem Struct Biol; 2024; 139():469-499. PubMed ID: 38448143
[TBL] [Abstract][Full Text] [Related]
20. A Comprehensive Pan-Cancer Analysis of the Tumorigenic Role of Matrix Metallopeptidase 7 (MMP7) Across Human Cancers.
Meng N; Li Y; Jiang P; Bu X; Ding J; Wang Y; Zhou X; Yu F; Zhang Y; Zhang J; Xia L
Front Oncol; 2022; 12():916907. PubMed ID: 35785154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
